Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 3/20 | 0.55 |
| ▸ | CES2 | O00748 | 3/20 | 0.48 |
| ▸ | CES1 | P23141 | 3/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | PPARG | P37231 | 6/20 | 0.46 |
| ▸ | PPARD | Q03181 | 6/20 | 0.46 |
| ▸ | PPARA | Q07869 | 6/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26444136 | 1.00 | NAAA (0.55) | NAAACES2CES1GPR84PPARG | |
| SCHEMBL2126939 | 1.00 | NAAA (0.55) | NAAACES2CES1GPR84PPARG | |
| SCHEMBL2126800 | 1.00 | NAAA (0.55) | NAAACES2CES1GPR84PPARG | |
| SCHEMBL2125001 | 1.00 | NAAA (0.55) | NAAACES2CES1GPR84PPARG | |
| SCHEMBL2126627 | 1.00 | NAAA (0.55) | NAAACES2CES1GPR84PPARG | |
| SCHEMBL10960947 | 0.98 | NAAA (0.56) | NAAACES2CES1GPR84PPARG | |
| SCHEMBL10959885 | 0.98 | NAAA (0.56) | NAAACES2CES1GPR84PPARG | |
| SCHEMBL10960913 | 0.98 | NAAA (0.56) | NAAACES2CES1GPR84PPARG | |
| SCHEMBL10960790 | 0.98 | NAAA (0.56) | NAAACES2CES1GPR84PPARG | |
| SCHEMBL2126029 | 0.98 | NAAA (0.56) | NAAACES2CES1GPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8716531-B2 | Method for producing norbornene derivative | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2014-05-06 | — | — | US | disclosed |
| US-20120108851-A1 | METHOD FOR PRODUCING NORBORNENE DERIVATIVE | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2012-05-03 | — | — | US | disclosed |
| EP-2444386-A1 | PROCESS FOR PREPARATION OF NORBORNENE DERIVATIVES | JX Nippon Oil & Energy Corporation (JP) | 2012-04-25 | — | — | EP | disclosed |
| EP-0513285-A1 | IMIDAZOL-2-YL DERIVATIVES OF SUBSTITUTED BICYCLIC COMPOUNDS AND PROCESS FOR THEIR PREPARATION. | ERBA CARLO SPA (IT) | 1992-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108851-A1 | METHOD FOR PRODUCING NORBORNENE DERIVATIVE | UGT1A8, UGT8, ALG8 | NAAA 890/4885CES2 1994/4885CES1 1690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.